Login / Signup

Designing Selective Drug-like Molecular Glues for the Glucocorticoid Receptor/14-3-3 Protein-Protein Interaction.

Jakob S PallesenClaire C MunierFrancesco BosicaSebastian A AndreiKarl EdmanAnders GunnarssonGiuseppina La SalaOkky Dwichandra PutraSonja SrdanovićAndrew J WilsonLisa WisslerChristian OttmannMatthew W D PerryGavin O'Mahony
Published in: Journal of medicinal chemistry (2022)
The ubiquitously expressed glucocorticoid receptor (GR) is a nuclear receptor that controls a broad range of biological processes and is activated by steroidal glucocorticoids such as hydrocortisone or dexamethasone. Glucocorticoids are used to treat a wide variety of conditions, from inflammation to cancer but suffer from a range of side effects that motivate the search for safer GR modulators. GR is also regulated outside the steroid-binding site through protein-protein interactions (PPIs) with 14-3-3 adapter proteins. Manipulation of these PPIs will provide insights into noncanonical GR signaling as well as a new level of control over GR activity. We report the first molecular glues that selectively stabilize the 14-3-3/GR PPI using the related nuclear receptor estrogen receptor α (ERα) as a selectivity target to drive design. These 14-3-3/GR PPI stabilizers can be used to dissect noncanonical GR signaling and enable the development of novel atypical GR modulators.
Keyphrases
  • protein protein
  • estrogen receptor
  • small molecule
  • oxidative stress
  • emergency department
  • low dose
  • squamous cell carcinoma
  • high dose
  • young adults
  • papillary thyroid
  • drug induced
  • anti inflammatory drugs